CNS activity of trastuzumab deruxtecan in HER2-expressing non-small-cell lung cancer

被引：0
|
作者：
Lazaratos, Anna-Maria [1 ]
Petrecca, Kevin [2 ]
Guiot, Marie-Christine [2 ]
Dankner, Matthew [1 ]
Jerzak, Katarzyna J. [3 ]
机构：
[1] McGill Univ, Rosalind & Morris Goodman Canc Res Inst, Montreal, PQ H3A 1A3, Canada
[2] McGill Univ, Montreal Neurol Inst Hosp, Montreal, PQ H3A 1A3, Canada
[3] Univ Toronto, Sunnybrook Odette Canc Ctr, Div Med Oncol, Toronto, ON, Canada
来源：
LANCET ONCOLOGY | 2024年 / 25卷 / 07期
关键词：
BRAIN METASTASES;
D O I：
10.1016/S1470-2045(24)00261-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：e282 / e282
页数：1
相关论文
共 50 条
  • [21] Trastuzumab Emtansine in HER2+Recurrent Metastatic Non-Small-Cell Lung Cancer: Study Protocol
    Ohashi, Kadoaki
    Hotta, Katsuyuki
    Hirata, Taizo
    Aoe, Keisuke
    Kozuki, Toshiyuki
    Ninomiya, Kiichiro
    Kayatani, Hiroe
    Yanai, Hiroyuki
    Toyooka, Shinichi
    Hinotsu, Shiro
    Takata, Minoru
    Kiura, Katsuyuki
    CLINICAL LUNG CANCER, 2017, 18 (01) : 92 - 95
  • [22] Trastuzumab Deruxtecan in HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Interim Results of DESTINY-Lung01
    Nakagawa, K.
    Nagasaka, M.
    Felip, E.
    Pacheco, J.
    Baik, C.
    Goto, Y.
    Saltos, A.
    Li, B.
    Udagawa, H.
    Gadgeel, S.
    Murakami, H.
    Planchard, D.
    Bazhenova, L.
    Paz-Ares, L.
    Perol, M.
    Mazieres, J.
    Barlesi, F.
    Saxena, K.
    Shiga, R.
    Acharyya, S.
    Cheng, Y.
    Shahidi, J.
    Janne, P.
    Smit, E.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S109 - S110
  • [23] A multicenter, multicohort, phase II study of trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing metastatic colorectal cancer
    Yoshino, T.
    Siena, S.
    Dalal, R.
    Okuda, Y.
    Yamamoto, E.
    Grothey, A.
    ANNALS OF ONCOLOGY, 2018, 29 : 45 - 45
  • [24] Efficacy with Trastuzumab Deruxtecan for Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutation in a Patient with a Poor Performance Status: A Case Report
    Kato, Yuki
    Kato, Yasuhiro
    Minegishi, Yuji
    Suzuki, Takahiro
    Nakamichi, Shinji
    Matsumoto, Masaru
    Miyanaga, Akihiko
    Noro, Rintaro
    Kubota, Kaoru
    Terasaki, Yasuhiro
    Seike, Masahiro
    Gemma, Akihiko
    ONCOTARGETS AND THERAPY, 2021, 14 : 5315 - 5319
  • [25] Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial
    Goto, Koichi
    Goto, Yasushi
    Kubo, Toshio
    Ninomiya, Kiichiro
    Kim, Sang-We
    Planchard, David
    Ahn, Myung-Ju
    Smit, Egbert F.
    de Langen, Adrianus Johannes
    Perol, Maurice
    Pons-Tostivint, Elvire
    Novello, Silvia
    Hayashi, Hidetoshi
    Shimizu, Junichi
    Kim, Dong-Wan
    Kuo, Chih-Hsi
    Yang, James Chih-Hsin
    Pereira, Kaline
    Cheng, Fu-Chih
    Taguchi, Ayumi
    Cheng, Yingkai
    Feng, Wenqin
    Tsuchihashi, Zenta
    Janne, Pasi A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (31) : 4852 - +
  • [26] Pharmacokinetics, Safety, and Efficacy of Trastuzumab Deruxtecan with Concomitant Ritonavir or Itraconazole in Patients with HER2-Expressing Advanced Solid Tumors
    Takahashi, Shunji
    Karayama, Masato
    Takahashi, Masato
    Watanabe, Junichiro
    Minami, Hironobu
    Yamamoto, Noboru
    Kinoshita, Ichiro
    Lin, Chia-Chi
    Im, Young-Hyuck
    Achiwa, Issei
    Kamiyama, Emi
    Okuda, Yasuyuki
    Lee, Caleb
    Bang, Yung-Jue
    CLINICAL CANCER RESEARCH, 2021, 27 (21) : 5771 - 5780
  • [27] Trastuzumab in the treatment of advanced non-small-cell lung cancer: Is there a role?
    Kalemkerian, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) : 1325 - 1326
  • [28] Trastuzumab Deruxtecan in Patients with HER2-Mutant Metastatic Non-Small Cell Lung Cancer: Primary Results of DESTINY-Lung02
    Janne, P.
    Goto, Y.
    Kubo, T.
    Ninomiya, K.
    Kim, S. -W.
    Planchard, D.
    Ahn, M. -J.
    Smit, E. F.
    de Langen, A. J.
    Perol, M.
    Pons-Tostivint, E.
    Novello, S.
    Hayashi, H.
    Shimizu, J.
    Kim, D. -W.
    Pereira, K.
    Cheng, F. -C.
    Taguchi, A.
    Cheng, Y.
    Goto, K.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S148 - S148
  • [29] Real-world evidence of Trastuzumab Deruxtecan (T-DXd) Efficacy in HER2-expressing gynecological malignancies
    Andrikopoulou, Angeliki
    Zagouri, Flora
    Goula, Kallirroi
    Haidopoulos, Dimitrios
    Thomakos, Nikolaos
    Svarna, Anna
    Dimopoulos, Meletios-Athanasios
    Liontos, Michalis
    BMC CANCER, 2024, 24 (01)
  • [30] Trastuzumab Deruxtecan in HER2-Mutated Metastatic Non-Small Cell Lung Cancer (NSCLC): Interim Results of DESTINY-Lung01
    Smit, E.
    Nakagawa, K.
    Nagasaka, M.
    Felip, E.
    Goto, Y.
    Li, B.
    Pacheco, J.
    Murakami, H.
    Barlesi, F.
    Saltos, A.
    Perol, M.
    Udagawa, H.
    Saxena, K.
    Shiga, R.
    Guevara, F.
    Acharyya, S.
    Shahidi, J.
    Planchard, D.
    Janne, P.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S173 - S173
12345